| Original language | English |
|---|---|
| Pages (from-to) | 17-17 |
| Number of pages | 1 |
| Journal | Neuro-Oncology |
| Volume | 19 |
| Publication status | Published - Nov 2017 |
| Event | 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology - San Francisco, United States Duration: 16 Nov 2017 → 19 Nov 2017 |
Cite this
}
A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC). / Cher, Lawrence; Nowak, Anna; Iatropoulos, George; Lee, Weon Sup; Lee, Seon Young; Shim, Sang Ryeol; Yoo, Jin San.
In: Neuro-Oncology, Vol. 19, 11.2017, p. 17-17.Research output: Contribution to journal › Abstract/Meeting Abstract
TY - JOUR
T1 - A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC)
AU - Cher, Lawrence
AU - Nowak, Anna
AU - Iatropoulos, George
AU - Lee, Weon Sup
AU - Lee, Seon Young
AU - Shim, Sang Ryeol
AU - Yoo, Jin San
PY - 2017/11
Y1 - 2017/11
M3 - Abstract/Meeting Abstract
VL - 19
SP - 17
EP - 17
JO - Neuro-Oncology
JF - Neuro-Oncology
SN - 1522-8517
ER -